Biocartis
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.
Biocartis, Merck KGaA Extend RAS Testing Partnership to Middle East, North Africa
The companies hope to improve access to biomarker testing to direct more personalized treatment for cancer patients in the region.
In Brief This Week: Olema Oncology, Eckert & Ziegler, Kazia Therapeutics, Myriad Genetics, Biocartis
News items for the week of Oct. 9, 2023.News items for the week of Oct.
Biocartis, Eli Lilly Partner for Spanish NSCLC Biomarker Study
The study aims to establish how Biocartis' Idylla molecular testing platform can eventually be used to improve community-based diagnostic workflows in the US.
Biocartis, Apis Assay Technologies to Develop Breast Cancer Subtyping Test
Apis will lead the development of the test on Biocartis' Idylla platform, while Biocartis will lead the commercialization of the assay.
Jun 22, 2022
Biocartis, AstraZeneca Ink Companion Diagnostic Pact
Jun 20, 2022